HAZELTON, Pa. — Troy Healthcare on Wednesday announced its purchase of the Stopain brand from DRJ Group and also stated that a new Stopain gel line extension will be shipping to stores in early 2011.
“With eight years of manufacturing knowledge and experience with Stopain products, Troy Healthcare will utilize its proven expertise in research and development to take the Stopain product line to the next level,” stated Bob Miller, Troy Healthcare spokesman. “The release of Stopain gel substantiates the company’s pledge to develop scientifically advanced products for healthy living.”
The new Stopain pain-relieving gel contains 38% more of the active ingredient menthol than any other product in the cooling gel category, the company stated. Suggested retail price for a 2.5-oz. tube is $5.99.
Troy Manufacturing, the owner of Troy Healthcare and a manufacturer of topical analgesic products, has produced the Stopain brand of products since 2002.